Adhera Therapeutics, Inc. (ATRX)
Stock Price: $0.1200 USD
-0.0100 (-7.69%)
Updated Jun 15, 2021 3:49 PM EDT - Market closed
| Market Cap | 1.51M |
| Revenue (ttm) | 132,000 |
| Net Income (ttm) | -4.40M |
| Shares Out | 11.19M |
| EPS (ttm) | -0.40 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 15 |
| Last Price | $0.1200 |
| Previous Close | $0.1300 |
| Change ($) | -0.0100 |
| Change (%) | -7.69% |
| Day's Open | 0.1400 |
| Day's Range | 0.1140 - 0.1500 |
| Day's Volume | 83,549 |
| 52-Week Range | 0.0340 - 0.1500 |
News
There are no news available yet.
About ATRX
Adhera Therapeutics, Inc. does not have significant operations. Previously, it was involved in the development and commercialization of drug therapeutics for chronic and acute diseases in the United States. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
| Industry Biotechnology | |
| Stock Exchange OTCMKTS | Ticker Symbol ATRX |